Imagen de Portada
Código QR

Prognostic factors identified in patients taking PCa Tx.

Publicado en:Urology Times Vol. 44; no. 2; pp. 10 - 12
Autor principal: Guttman Krader, Cheryl
Formato: Journal Article
Publicado: MJH Life Sciences Feb2016
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=113090815&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 113090815
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        00939722
        URO
      jtl: Urology Times
      issn: 00939722
      maglogo: N
    pubinfo:
      dt: Feb2016
      vid: 44
      iid: 2
      pid: 54670
      pub: MJH Life Sciences
      place: Cranbury, New Jersey
    artinfo:
      ui:
        113090815
        113090815
      ppf: 10
      ppct: 2
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Prognostic factors identified in patients taking PCa Tx.
      aug:
        au: Guttman Krader, Cheryl
      sug:
        subj:
          Prostatic Neoplasms Prognosis
          Prostatic Neoplasms Radiotherapy
          Radium Classification
          Chemotherapy, Cancer
          Survival Analysis
      pubtype: Academic Journal
      doctype: Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N